The University of California at San Francisco Diabetes Center, an organized research unit, has functioned for more than a half-century as a basic and clinical research enterprise at the forefront of diabetes research. Historically, the program has participated in seminar series, supported early stage research, and emphasized a strong basic and clinical research interface. The goal of the Center is to support a highly interactive team investigating Type 1 and Type 2 diabetes to advance the study and treatment of the disease. The Center encompasses a broad range of intellectual and research expertise from 21 departments and organized research units and four UCSF campuses focused on both basic and clinical research. In this application, the UCSF Diabetes Center proposes to renew its Diabetes and Endocrinology Research Center (DERC) grant funding that supports the following activities: An Administrative Core that provides leadership, infrastructure, administrative support, and advice and oversight to the other components and members of the DERC, and interfaces with the NIDDK, other NIH Diabetes Centers, and the lay community. Biomedical Medical Research Cores Islet Metabolism Core Cytometry and Cell Sorting Core Microscopy Core Mouse Genetics Core A Pilot &Feasibility Program that funds small innovative projects that support new investigators, explore novel areas of investigators for established investigators, attract new investigators to the DERC, promote interactions and lead to external support to further the goals of the DERC. An Enrichment Program that furthers the goals of the DERC by enhancing scientific exchange and training with seminar series, invited speakers and an annual retreat.
The support requested in this application will provide the infrastructure, core laboratories, pilot and feasibility grants, and enrichment programs that will accentuate the collaboration and accelerate the progress of 56 principal investigators at UCSF and their associated groups studying diabetes with the goal of advancing the study and treatment of Type 1 and Type 2 diabetes.
|Kim, Charles C; Nakamura, Mary C; Hsieh, Christine L (2016) Brain trauma elicits non-canonical macrophage activation states. J Neuroinflammation 13:117|
|Lyles, Courtney R; Seligman, Hilary K; Parker, Melissa M et al. (2016) Financial Strain and Medication Adherence among Diabetes Patients in an Integrated Health Care Delivery System: The Diabetes Study of Northern California (DISTANCE). Health Serv Res 51:610-24|
|Stock, Peter G; German, Michael S (2016) A Path to Insulin Independence: "The End of the Beginning". Cell Stem Cell 18:431-3|
|Faleo, Gaetano; Lee, Karim; Nguyen, Vinh et al. (2016) Assessment of Immune Isolation of Allogeneic Mouse Pancreatic Progenitor Cells by a Macroencapsulation Device. Transplantation 100:1211-8|
|Wilson, Camella G; Tran, Jennifer L; Erion, Derek M et al. (2016) Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice. Endocrinology 157:570-85|
|Robblee, Megan M; Kim, Charles C; Porter Abate, Jess et al. (2016) Saturated Fatty Acids Engage an IRE1Î±-Dependent Pathway to Activate the NLRP3 Inflammasome in Myeloid Cells. Cell Rep 14:2611-23|
|Chan, Alice Y; Punwani, Divya; Kadlecek, Theresa A et al. (2016) A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70. J Exp Med 213:155-65|
|Shah, A D; Kandula, N R; Lin, F et al. (2016) Less favorable body composition and adipokines in South Asians compared with other US ethnic groups: results from the MASALA and MESA studies. Int J Obes (Lond) 40:639-45|
|Ye, Lin; Wang, Jiaming; Tan, Yuting et al. (2016) Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and Î²-thalassemia. Proc Natl Acad Sci U S A 113:10661-5|
|von Moltke, Jakob; Ji, Ming; Liang, Hong-Erh et al. (2016) Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit. Nature 529:221-5|
Showing the most recent 10 out of 454 publications